Regeneron Pharmaceuticals... (REGN)
NASDAQ: REGN
· Real-Time Price · USD
573.95
-6.46 (-1.11%)
At close: Aug 18, 2025, 3:59 PM
573.98
0.01%
Pre-market: Aug 19, 2025, 08:08 AM EDT
Regeneron Pharmaceuticals Revenue
Regeneron Pharmaceuticals reported an annual revenue of $14.2B, reflecting a 8.27% growth. For the quarter ending June 30, 2025, Regeneron Pharmaceuticals generated $3.68B in revenue.
Revenue (ttm)
14.2B
Revenue Growth
8.27%
Price / Sales Ratio
5.41
Revenue / Employee
936.93K
Employees
15,158
Market Cap
59.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 14.2B | +8.27% |
| Dec 31, 2023 | 13.12B | +7.76% |
| Dec 31, 2022 | 12.17B | -24.26% |
| Dec 31, 2021 | 16.07B | +89.14% |
| Dec 31, 2020 | 8.5B | +29.58% |
| Dec 31, 2019 | 6.56B | -2.28% |
| Dec 31, 2018 | 6.71B | +14.28% |
| Dec 31, 2017 | 5.87B | +20.82% |
| Dec 31, 2016 | 4.86B | +18.44% |
| Dec 31, 2015 | 4.1B | +45.55% |
| Dec 31, 2014 | 2.82B | +33.96% |
| Dec 31, 2013 | 2.1B | +52.69% |
| Dec 31, 2012 | 1.38B | +209.20% |
| Dec 31, 2011 | 445.82M | -2.89% |
| Dec 31, 2010 | 459.07M | +21.04% |
| Dec 31, 2009 | 379.27M | +59.05% |
| Dec 31, 2008 | 238.46M | +90.73% |
| Dec 31, 2007 | 125.02M | +97.05% |
| Dec 31, 2006 | 63.45M | -4.15% |
| Dec 31, 2005 | 66.19M | -61.96% |
| Dec 31, 2004 | 174.02M | +202.65% |
| Dec 31, 2003 | 57.5M | +161.49% |
| Dec 31, 2002 | 21.99M | +0.07% |
| Dec 31, 2001 | 21.97M | -62.93% |
| Dec 31, 2000 | 59.28M | +71.81% |
| Dec 31, 1999 | 34.5M | -9.69% |
| Dec 31, 1998 | 38.2M | +15.41% |
| Dec 31, 1997 | 33.1M | +37.34% |
| Dec 31, 1996 | 24.1M | -12.04% |
| Dec 31, 1995 | 27.4M | +18.10% |
| Dec 31, 1994 | 23.2M | +118.87% |
| Dec 31, 1993 | 10.6M | -7.83% |
| Dec 31, 1992 | 11.5M | +57.53% |
| Dec 31, 1991 | 7.3M | +46.00% |
| Dec 31, 1990 | 5M | n/a |